However, 4 out of 19 probes showed that increased mdig expression, in fact, predicts a better overall survival of the pancreatic cancer patients, which most likely indicated a different or opposite function of the alternatively spliced mdig mRNAs. This evidence concerns the gene RIOX2 and pancreatic neoplasm.